Protara Therapeutics, Inc. (TARA)

Latest Insider Confidence Score

2026Q1

46.3
Bearish

Company insider confidence (by quarter)

2014Q4 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Prism Venture Partners V L P — 19,535,282 Oct 22, 2014
Prism Venture Partners V-A LP — 19,535,282 Oct 22, 2014
Opaleye, L.P. — 2,208,472 Jan 13, 2020
Deerfield Mgmt IV, L.P. — 1,224,899 Aug 4, 2017
Deerfield Private Design Fund IV, L.P. — 1,224,899 Aug 4, 2017

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 26, 2026 Jan 27, 2026 Fry Hannah VP, Controller Sell 27.5 -1,457 -3.30% ✗ $9.7K
Jan 26, 2026 Jan 27, 2026 Fabbio Patrick CFO Sell 26.3 -3,261 -4.84% ✗ $21.8K
Jan 26, 2026 Jan 27, 2026 Shefferman Jesse CEO Sell 32.5 -8,732 -0.85% ✗ $58.2K
Jan 26, 2026 Jan 27, 2026 Zummo Jacqueline Chf Scientific Operations Off Sell 26.3 -3,724 -3.05% ✗ $24.8K
Jan 20, 2026 Jan 22, 2026 Shefferman Jesse CEO Sell 22.5 -16,322 -1.56% ✗ $91.4K
Jan 20, 2026 Jan 22, 2026 Fabbio Patrick CFO Sell 26.3 -3,063 -4.35% ✗ $17.2K
Jan 20, 2026 Jan 22, 2026 Zummo Jacqueline Chf Scientific Operations Off Sell 26.3 -6,578 -5.10% ✗ $36.8K
Jan 20, 2026 Jan 22, 2026 Fry Hannah VP, Controller Sell 26.3 -2,132 -4.60% ✗ $11.9K
Jan 16, 2026 Jan 21, 2026 CONKLING WILLIAM Chief Commercial Officer Neutral 90.0 +26,000 52.00% ✗ -
Jan 16, 2026 Jan 21, 2026 Fabbio Patrick CFO Neutral 90.0 +28,000 65.98% ✗ -
Jan 16, 2026 Jan 21, 2026 Fry Hannah VP, Controller Neutral 90.0 +9,500 25.81% ✗ -
Jan 16, 2026 Jan 21, 2026 Nicacio Leonardo Viana Chief Medical Officer Neutral 90.0 +26,000 49.83% ✗ -
Jan 16, 2026 Jan 21, 2026 Shefferman Jesse CEO Neutral 85.0 +87,000 9.06% ✗ -
Jan 16, 2026 Jan 21, 2026 Zummo Jacqueline Chf Scientific Operations Off Neutral 90.0 +30,000 30.35% ✗ -
Jun 24, 2025 Jul 7, 2025 Shefferman Jesse CEO Neutral 27.5 -300,000 -23.81% ✗ -
Jun 26, 2025 Jun 30, 2025 Shefferman Jesse CEO Neutral 27.5 -18,667 -1.91% ✗ -
Jun 12, 2025 Jun 13, 2025 SARGEN GREGORY Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2025 Jun 13, 2025 Levy Richard S Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2025 Jun 13, 2025 Solomon Michael Edward Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2025 Jun 13, 2025 Huang Jane Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2025 Jun 13, 2025 GARCEAU ROGER Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2025 Jun 13, 2025 Smith Cynthia Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2025 Jun 13, 2025 Flannelly Barry P Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2025 Jun 13, 2025 BESHAR LUKE M Director Neutral 52.5 - 0.00% ✗ -
Jun 2, 2025 Jun 4, 2025 CONKLING WILLIAM Chief Commercial Officer Neutral 90.0 +50,000 100.00% ✗ -
Jun 4, 2025 CONKLING WILLIAM Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
May 14, 2025 May 19, 2025 Levy Richard S Director Buy 95.0 +20,000 64.52% ✗ $63.8K
May 14, 2025 May 16, 2025 Levy Richard S Director Buy 95.0 +20,000 64.52% ✗ $63.8K
Apr 15, 2025 Apr 17, 2025 Nicacio Leonardo Viana Chief Medical Officer Neutral 90.0 +50,000 2292.53% ✗ -
Apr 17, 2025 Nicacio Leonardo Viana Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Mar 26, 2025 Mar 28, 2025 Zummo Jacqueline Chf Scientific Operations Off Sell 20.0 -21,224 -17.67% ✓ $96.1K
Mar 28, 2025 Fabbio Patrick CFO Neutral 52.5 - 0.00% ✗ -
Mar 28, 2025 Shefferman Jesse CEO Neutral 52.5 - 0.00% ✗ -
Mar 28, 2025 Fry Hannah VP, Controller Neutral 52.5 - 0.00% ✗ -
Mar 28, 2025 Zummo Jacqueline Chf Scientific Operations Off Neutral 52.5 - 0.00% ✗ -
Jan 24, 2025 Jan 28, 2025 Shefferman Jesse CEO Neutral 85.0 +65,000 7.00% ✗ -
Jan 24, 2025 Jan 28, 2025 Zummo Jacqueline Chf Scientific Operations Off Neutral 90.0 +24,500 23.99% ✗ -
Jan 24, 2025 Jan 28, 2025 Fry Hannah VP, Controller Neutral 90.0 +9,500 32.27% ✗ -
Jan 24, 2025 Jan 28, 2025 Fabbio Patrick CFO Neutral 90.0 +23,500 106.82% ✗ -
Jan 21, 2025 Jan 23, 2025 Shefferman Jesse CEO Sell 22.5 -15,469 -1.67% ✗ $73.6K
Jan 21, 2025 Jan 23, 2025 Fabbio Patrick CFO Sell 26.3 -3,061 -13.91% ✗ $14.6K
Jan 21, 2025 Jan 23, 2025 Fry Hannah VP, Controller Sell 26.3 -2,130 -7.23% ✗ $10.1K
Jan 21, 2025 Jan 23, 2025 Zummo Jacqueline Chf Scientific Operations Off Sell 26.3 -6,554 -6.42% ✗ $31.2K
Jan 3, 2025 Jan 7, 2025 Shefferman Jesse CEO Sell 36.3 -6,479 -0.69% ✗ $39.8K
Jan 3, 2025 Jan 7, 2025 Zummo Jacqueline Chf Scientific Operations Off Sell 26.3 -2,157 -2.07% ✗ $13.2K
Jan 3, 2025 Jan 7, 2025 Fry Hannah VP, Controller Sell 27.5 -394 -1.32% ✗ $2.4K
Sep 11, 2024 Sep 12, 2024 Opaleye Management Inc. 10% Owner Sell 20.0 -158,901 -7.40% ✗ $271.7K
Sep 9, 2024 Sep 10, 2024 Opaleye Management Inc. 10% Owner Sell 22.5 -61,992 -2.81% ✗ $114.3K
Aug 28, 2024 Aug 30, 2024 Shefferman Jesse CEO Neutral 37.5 -8,563 -0.91% ✗ -
Jul 16, 2024 Jul 18, 2024 Opaleye Management Inc. 10% Owner Sell 36.3 -11,396 -0.51% ✗ $27.8K
Jul 9, 2024 Jul 11, 2024 Opaleye Management Inc. 10% Owner Sell 22.5 -74,551 -3.25% ✗ $175.8K
Jul 1, 2024 Jul 3, 2024 Opaleye Management Inc. 10% Owner Sell 43.8 -8,288 -0.36% ✗ $17.6K
Jun 27, 2024 Jun 28, 2024 Opaleye Management Inc. 10% Owner Sell 22.5 -64,568 -2.73% ✗ $142.5K
Jun 25, 2024 Jun 27, 2024 Opaleye Management Inc. 10% Owner Sell 36.3 -12,725 -0.53% ✗ $28.7K
Jun 7, 2024 Jun 10, 2024 Flannelly Barry P Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2024 Jun 10, 2024 Smith Cynthia Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2024 Jun 10, 2024 Solomon Michael Edward Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2024 Jun 10, 2024 SARGEN GREGORY Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2024 Jun 10, 2024 Levy Richard S Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2024 Jun 10, 2024 Huang Jane Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2024 Jun 10, 2024 GARCEAU ROGER Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2024 Jun 10, 2024 BESHAR LUKE M Director Neutral 52.5 - 0.00% ✗ -
May 30, 2024 May 31, 2024 Opaleye Management Inc. 10% Owner Sell 26.3 -15,054 -12.16% ✗ $44K
May 21, 2024 May 23, 2024 Opaleye Management Inc. 10% Owner Sell 32.5 -42,800 -0.88% ✗ $130.4K
May 17, 2024 May 17, 2024 Opaleye Management Inc. 10% Owner Sell 22.5 -70,885 -2.82% ✗ $230.3K
May 9, 2024 May 10, 2024 Opaleye Management Inc. 10% Owner Sell 20.0 -182,300 -7.11% ✗ $567K
Jan 19, 2024 Jan 23, 2024 Shefferman Jesse CEO Sell 86.3 +51,197 5.73% ✗ $14.9K
Jan 19, 2024 Jan 23, 2024 Bandari Jathin Chief Medical Officer Sell 90.0 +20,121 55.00% ✗ $5.5K
Jan 19, 2024 Jan 23, 2024 Zummo Jacqueline Chf Scientific Operations Off Sell 90.0 +19,951 23.65% ✗ $5.8K
Jan 19, 2024 Jan 23, 2024 Fabbio Patrick CFO Neutral 90.0 +22,000 100.00% ✗ -
Jan 19, 2024 Jan 23, 2024 Fry Hannah VP, Controller Sell 90.0 +7,096 31.20% ✗ $1.7K
Jan 10, 2024 Jan 12, 2024 Shefferman Jesse CEO Sell 36.3 -5,746 -0.64% ✗ $13.7K
Jan 10, 2024 Jan 12, 2024 Zummo Jacqueline Chf Scientific Operations Off Sell 26.3 -5,229 -5.84% ✗ $12.5K
Jan 10, 2024 Jan 12, 2024 Bandari Jathin Chief Medical Officer Sell 27.5 -1,877 -4.88% ✗ $4.5K
Jan 3, 2024 Jan 5, 2024 Zummo Jacqueline Chf Scientific Operations Off Sell 27.5 -1,899 -2.08% ✗ $4.1K
Jan 3, 2024 Jan 5, 2024 Shefferman Jesse CEO Sell 36.3 -5,840 -0.65% ✗ $12.7K
Jan 3, 2024 Jan 5, 2024 Fry Hannah VP, Controller Sell 27.5 -324 -1.40% ✗ $703.1
Jul 17, 2023 Jul 18, 2023 Fry Hannah VP, Controller Sell 26.3 -10,075 -30.40% ✗ $25.8K
Jul 3, 2023 Jul 5, 2023 Bandari Jathin Chief Medical Officer Sell 27.5 -682 -1.74% ✗ $1.7K
Jun 23, 2023 Jun 27, 2023 Shefferman Jesse CEO Neutral 27.5 -9,310 -1.02% ✗ -
Jun 7, 2023 Jun 8, 2023 Smith Cynthia Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2023 Jun 8, 2023 BESHAR LUKE M Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2023 Jun 8, 2023 GARCEAU ROGER Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2023 Jun 8, 2023 SARGEN GREGORY Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2023 Jun 8, 2023 Levy Richard S Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2023 Jun 8, 2023 Solomon Michael Edward Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2023 Jun 8, 2023 Huang Jane Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2023 Jun 8, 2023 Flannelly Barry P Director Neutral 52.5 - 0.00% ✗ -
Jun 27, 2022 Feb 10, 2023 Shefferman Jesse CEO Neutral 45.0 -4,519 -0.49% ✗ -
Jan 30, 2023 Jan 30, 2023 Fabbio Patrick CFO Neutral 52.5 - 0.00% ✗ -
Jan 30, 2023 Fabbio Patrick CFO Neutral 52.5 - 0.00% ✗ -
Jan 19, 2023 Jan 20, 2023 Shefferman Jesse CEO Neutral 85.0 +51,300 5.92% ✗ -
Jan 19, 2023 Jan 20, 2023 Fry Hannah VP, Controller Neutral 90.0 +5,900 21.66% ✗ -
Jan 19, 2023 Jan 20, 2023 Zummo Jacqueline Chf Scientific Operations Off Neutral 90.0 +19,900 27.80% ✗ -
Jan 19, 2023 Jan 20, 2023 Bandari Jathin Chief Medical Officer Neutral 90.0 +20,700 112.24% ✗ -
Jan 10, 2023 Jan 11, 2023 Zummo Jacqueline Chf Scientific Operations Off Sell 26.3 -5,225 -6.80% ✗ $15.7K
Jan 10, 2023 Jan 11, 2023 Shefferman Jesse CEO Sell 36.3 -5,855 -0.67% ✗ $17.6K
Jan 10, 2023 Jan 11, 2023 Bandari Jathin Chief Medical Officer Sell 27.5 -1,876 -9.23% ✗ $5.6K
Jan 3, 2023 Jan 4, 2023 Zummo Jacqueline Chf Scientific Operations Off Sell 27.5 -2,159 -2.73% ✗ $6K
Jan 3, 2023 Jan 4, 2023 Shefferman Jesse CEO Sell 36.3 -6,604 -0.75% ✗ $18.5K